Follow
Michael J. DiStefano, PhD M. Bioethics
Michael J. DiStefano, PhD M. Bioethics
University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
Verified email at cuanschutz.edu
Title
Cited by
Cited by
Year
mHealth for tuberculosis treatment adherence: a framework to guide ethical planning, implementation, and evaluation
MJ DiStefano, H Schmidt
Global Health: Science and Practice 4 (2), 211-221, 2016
80*2016
Using External Reference Pricing In Medicare Part D To Reduce Drug Price Differentials With Other Countries
SY Kang, MJ DiStefano, MP Socal, GF Anderson
Health Affairs 38 (5), 804-811, 2019
382019
Comparative Approaches to Drug Pricing
SY Kang, G Bai, MJ DiStefano, MP Socal, F Yehia, GF Anderson
Annual Review of Public Health 41 (1), 2020
292020
Beyond the numbers: a critique of quantitative multi-criteria decision analysis
MJ DiStefano, CB Krubiner
International Journal of Technology Assessment in Health Care, https://doi …, 2020
232020
Assessing the Added Therapeutic Benefit of Ultra-Expensive Drugs
MJ DiStefano, SY Kang, F Yehia, C Morales, GF Anderson
Value in Health, 2021
132021
Ethics of mobile phone surveys to monitor non-communicable disease risk factors in low-and middle-income countries: A global stakeholder survey
J Ali, MJ DiStefano, I Coates McCall, DG Gibson, GM Al Kibria, GW Pariyo, ...
Global Public Health 14 (8), 1167-1181, 2019
132019
Public opinion regarding US Food and Drug Administration approval of aducanumab and potential policy responses: A nationally representative survey
MJ DiStefano, GC Alexander, D Polsky, GF Anderson
Journal of the American Geriatrics Society, 2022
122022
Does Incorporating Cost-Effectiveness Analysis Into Prescribing Decisions Promote Drug Access Equity?
MJ DiStefano, JS Levin
AMA Journal of Ethics 21 (8), E679-685, 2019
112019
Critical Care Beds With Continuous Lateral Rotation Therapy to Prevent Ventilator-Associated Pneumonia and Hospital-Acquired Pressure Injury: A Cost-effectiveness Analysis.
SY Kang, MJ DiStefano, F Yehia, MV Koszalka, WV Padula
Journal of Patient Safety, 2019
92019
Association Between Drug Characteristics and Manufacturer Spending on Direct-to-Consumer Advertising
MJ DiStefano, JM Markell, CC Doherty, GC Alexander, GF Anderson
JAMA 329 (5), 386-392, 2023
62023
Reflective solidarity as to provincial globalism and shared health governance
MJ DiStefano, J Prah Ruger
Diametros, 2015
62015
Integrating health technology assessment and the right to health: a qualitative content analysis of procedural values in South African judicial decisions
MJ DiStefano, S Abdool Karim, CB Krubiner
Health Policy and Planning, 2021
52021
Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial Insurance
MJ DiStefano, SY Kang, S Parasrampuria, GF Anderson
JAMA Health Forum 4 (5), e231090-e231090, 2023
42023
The Value of Explicit, Deliberative, and Context-Specified Ethics Analysis for Health Technology Assessment: Evidence From a Novel Approach Piloted in South Africa
CB Krubiner, A Tugendhaft, MJ DiStefano, NW Barsdorf, MW Merritt, ...
Value in Health Regional Issues 34, 23-30, 2023
42023
Introducing an Ethics Framework for health priority-setting in South Africa on the path to universal health coverage
D Blaauw, C Chambers, T Chirwa, N Duba, L Gwyther, K Hofman, ...
South African Medical Journal 112 (3), 240-244, 2022
42022
Developing and Piloting a Context-Specified Ethics Framework for Health Technology Assessment: The South African Values and Ethics for Universal Health Coverage (SAVE-UHC) Approach
CB Krubiner, NW Barsdorf, SJ Goldstein, A Mosam, S Potgieter, ...
International Journal of Technology Assessment in Health Care 38 (1), e26, 2022
42022
Health Systems Stewardship, Governance, and Accountability: Issues of Public Health Ethics
MJ DiStefano, JP Ruger
The Oxford Handbook of Public Health Ethics, 115-126, 2019
4*2019
Characterizing" Civil Unrest" as a Public Health Determinant
MJ DiStefano
American Journal of Public Health 108 (7), e20, 2018
42018
We need to talk about values: a proposed framework for the articulation of normative reasoning in health technology assessment
V Charlton, M DiStefano, P Mitchell, L Morrell, L Rand, G Badano, ...
Health Economics, Policy and Law, https://doi.org/10.1017/S174413312300003, 2023
32023
Wearable Biometric Technologies and Public Health
MJ DiStefano
The American Journal of Bioethics 17 (1), 79-81, 2017
32017
The system can't perform the operation now. Try again later.
Articles 1–20